Polyoma viral infection in renal transplantation: The role of immunosuppressive therapy

Clinical Transplantation

Volumn 15, Issue 4, 2001, Pages 240-246

  Barri, Yousri M ^a,d   Ahmad, Ibrahim ^b   Ketel, Beverley L ^c   Barone, Gary W ^d   Walker, Patrick D ^a   Bonsib, Stephen M ^a   Abul Ezz, Sameh R ^a  

^a Division of Nephrology   (United States)

^b Division of Transplant Surgery   (United States)

^c CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

^d UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

BK virus; Cyclosporine; Immunosuppression; Interstial nephritis; JC virus; Mycophenolate mofetil; Polyoma virus; Rejection; Tacrolimus transplant

Indexed keywords

ANTIVIRUS AGENT; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; TACROLIMUS;

ACUTE DISEASE; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRAFT FAILURE; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFECTION RISK; INTERSTITIAL NEPHRITIS; KIDNEY ALLOGRAFT; KIDNEY ALLOGRAFT REJECTION; KIDNEY BIOPSY; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MALE; POLYOMA VIRUS; PRIORITY JOURNAL; RISK FACTOR; VIRUS INFECTION;

ACUTE DISEASE; ADULT; CYCLOSPORINE; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; NEPHRITIS, INTERSTITIAL; POLYOMAVIRUS INFECTIONS; RISK FACTORS; TACROLIMUS; TUMOR VIRUS INFECTIONS;

EID: 0034906763     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0012.2001.150404.x     Document Type: Article

References (42)

1. New human papovavirus (BK) isolated from urine after renal transplantation
2. Prospective study of the human polyoma viruses BK and JC and cytomegalovirus in renal transplant recipients
3. Activation of human polyomavirus infection: Detection by cytologic techniques
4. High prevalence of antibodies to BK virus, and SV 40 related papovavirus, in residents of Maryland
5. Human polyomavirus (HPV): A significant pathogen in renal transplantation
6. Association of BK vivuria with hemorrhagic cystitis in recipients of bone marrow transplants
7. Prevalence of antibodies in human sera against JC virus, and isolate from a case of progressive multifocal leukoencephalopathy
8. Persistence of DNA sequences of BK virus and JC virus in normal human tissues and in diseased tissues
9. Human polyomavirus infection in renal allograft recipients
10. Disseminated BK type polyomavirus infection in an AIDS patient associated with central nervous system disease
11. Genotypes of human polyomaviruses in urine samples of pregnant women in Taiwan
12. Papovavirions in urothelium of treated lymphoma patients
13. Renal failure due to BK virus infection in an immunodeficient child
14. Human polyoma virus-associated interstitial nephritis in the allograft kidney
15. Polyomavirus-induced interstitial nephritis in two renal transplant recipients: Case reports and review of the literature
16. Polyomavirus infection of renal allograft recipients: From latent infection to manifest disease
17. Human polyomavirus in renal allograft biopsies: Morphological findings and correlation with urine cytology
18. JC, BK and other polyoma viruses
19. Diagnosis and management of BK polyomavirus interstitial nephritis in renal transplant recipients
20. Testing for polyomavirus type BK DNA in plasma to identify renal allograft recipients with viral nephropathy
21. Polyomavirus disease under new immunosuppressive drugs: A cause of renal dysfunction and graft loss
22. The increased incidence of BK polyoma virus in renal transplant recipients treated with Prograf
23. Increased infections associated with the use of OKT-3 for the treatment of steroid resistant rejection in renal transplantation
24. Symptomatic cytomegalovirus infection in renal transplant recipients given other Minnesota antilymphoblast globulin (MALG) or OKT-3 for rejection prophylaxis
25. Late-acute renal allograft rejection and symptomless cytomegalovirus infection
26. Effect of primary and recurrent cytomegalovirus infection upon graft and patient survival after renal transplantation
27. Cytomegalovirus infection-enhanced chronic kidney allograft rejection linked with intercellular adhesion molecule-1 expression
28. Renal allograft dysfunction associated with cytomegalovirus infection
29. Interstitial nephritis associated with cytomegalovirus infection
30. Severe tubulo-interstitial disease in a renal allograft due to cytomegalovirus infection
31. Cytomegalovirus colitis in a CMV-seropositive renal transplant recipient on triple drug therapy (including mycophenolate)
32. Prevalence of cytomegalovirus in the gastrointestinal tract of renal transplant recipients with persistent abdominal pain
33. Clear benefit of mycophenolate mofetil-based triple therapy in reducing the incidence of acute rejection after living donor renal transplantation
34. FK-506 versus cyclosporin for immunosuppression in renal transplantation: Meta-analysis of randomized trials
35. Tubulointerstitial disease
36. Value of lymphocyte characterization in diagnosis of polyoma virus allograft infection
37. Infectious complications in geriatric renal transplant patients: Comparison of two immunosuppressive protocols
38. Control of cytomegalovirus disease in renal transplant patients treated with prednisone, azathioprine, and cyclosporine using intensive monitoring and decreased immunosuppression
39. Human polyomavirus (BK) infection and ureteric stenosis in renal allograft recipients
40. Acyclic nucleoside phosphonates in the chemotherapy of DNA virus and retrovirus infections
41. Interferon and BK papovavirus-clinical and laboratory studies
42. Sequential vidarabine infusion in the treatment of polyoma virus-associated acute hemorrhagic cystitis late after allogeneic bone marrow transplantation